Volume 127, Issue 7 pp. 1604-1607
Head and Neck

Feasibility of endoscopic submandibular ganglion neurectomy for drooling

Kayhan Ozturk MD

Kayhan Ozturk MD

Department of Otolaryngology, Selcuk University, Konya, Turkey

Search for more papers by this author
Omer Erdur MD

Corresponding Author

Omer Erdur MD

Department of Otolaryngology, Selcuk University, Konya, Turkey

Send correspondence to Omer Erdur, MD, Selcuk University Medical School, Alaeddin Keykubad Campus, 42075 Yeni Istanbul Caddesi, Konya, Turkey. E-mail: [email protected]Search for more papers by this author
Osman Gul MD

Osman Gul MD

Department of Otolaryngology, Selcuk University, Konya, Turkey

Search for more papers by this author
Ayse Olmez MD

Ayse Olmez MD

Department of Otolaryngology, Selcuk University, Konya, Turkey

Search for more papers by this author
First published: 17 March 2017
Citations: 7

Institution where work was performed: Selcuk University, Hospital of Selcuklu, Konya, Turkey.

The authors have no funding, financial relationships, or conflicts of interest to disclose.

Abstract

We performed endoscopic transoral neurectomy of the submandibular and sublingual glands to treat drooling. We bilaterally operated two adult cases with treatment-resistant drooling. In these patients, conventional treatment had failed. Repeated botilinum toxin type A (BOTOX®, Abdi Ibrahim Pharmaceutical Company, Istanbul, Turkey) injections had been effective but were becoming less so. The patients benefited from surgery in that their saliva scores decreased. No issue emerged over 6 months of follow-up. Endoscopic transoral neurectomy of the submandibular and sublingual glands reduces saliva production and allows management of drooling in treatment-resistant patients. Laryngoscope, 127:1604–1607, 2017

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.